Pages that link to "Q55175927"

The following pages link to Sam Salman (Q55175927):

Displaying 41 items.

• Pharmacokinetic properties of azithromycin in pregnancy (Q33558917) (← links)
• Pharmacokinetics of chloroquine and monodesethylchloroquine in pregnancy (Q33676120) (← links)
• Transfer of parecoxib and its primary active metabolite valdecoxib via transitional breastmilk following intravenous parecoxib use after cesarean delivery: a comparison of naive pooled data analysis and nonlinear mixed-effects modeling (Q34161575) (← links)
• Development of a population pharmacokinetic model for parecoxib and its active metabolite valdecoxib after parenteral parecoxib administration in children. (Q34636955) (← links)
• Desbutyl-lumefantrine is a metabolite of lumefantrine with potent in vitro antimalarial activity that may influence artemether-lumefantrine treatment outcome. (Q34737444) (← links)
• Pharmacokinetic properties of conventional and double-dose sulfadoxine-pyrimethamine given as intermittent preventive treatment in infancy (Q34737758) (← links)
• Continuous infusions of meropenem in ambulatory care: clinical efficacy, safety and stability. (Q35206338) (← links)
• Population pharmacokinetics of artemether, lumefantrine, and their respective metabolites in Papua New Guinean children with uncomplicated malaria (Q35363704) (← links)
• Meningeal inflammation increases artemether concentrations in cerebrospinal fluid in Papua New Guinean children treated with intramuscular artemether. (Q35363936) (← links)
• Pharmacokinetics of a novel sublingual spray formulation of the antimalarial drug artemether in African children with malaria (Q35607695) (← links)
• Pharmacokinetics of a novel sublingual spray formulation of the antimalarial drug artemether in healthy adults (Q35607781) (← links)
• Pharmacokinetics of piperaquine transfer into the breast milk of Melanesian mothers (Q35746024) (← links)
• Population pharmacokinetics, tolerability, and safety of dihydroartemisinin-piperaquine and sulfadoxine-pyrimethamine-piperaquine in pregnant and nonpregnant Papua New Guinean women (Q35746240) (← links)
• Artemisinin-naphthoquine combination therapy for uncomplicated pediatric malaria: a pharmacokinetic study (Q35941440) (← links)
• Artemisinin-naphthoquine combination therapy for uncomplicated pediatric malaria: a tolerability, safety, and preliminary efficacy study (Q35941455) (← links)
• Pharmacokinetic comparison of two piperaquine-containing artemisinin combination therapies in Papua New Guinean children with uncomplicated malaria (Q36018642) (← links)
• Validation and Application of a Dried Blood Spot Ceftriaxone Assay (Q36439065) (← links)
• Safety, tolerability and pharmacokinetic properties of coadministered azithromycin and piperaquine in pregnant Papua New Guinean women (Q37030663) (← links)
• Validation and Application of a Dried Blood Spot Assay for Biofilm-Active Antibiotics Commonly Used for Treatment of Prosthetic Implant Infections. (Q37120112) (← links)
• Pharmacokinetic properties of sulfadoxine-pyrimethamine in pregnant women (Q37392749) (← links)
• Pharmacokinetic properties of single-dose primaquine in Papua New Guinean children: feasibility of abbreviated high-dose regimens for radical cure of vivax malaria (Q37544499) (← links)
• Optimal antimalarial dose regimens for chloroquine in pregnancy based on population pharmacokinetic modelling (Q38663801) (← links)
• Use of quantitative pharmacology tools to improve malaria treatments (Q38664529) (← links)
• Optimal Antimalarial Dose Regimens for Sulfadoxine-Pyrimethamine with or without Azithromycin in Pregnancy Based on Population Pharmacokinetic Modeling (Q38752586) (← links)
• Penicillin Dried Blood Spot Assay for Use in Patients Receiving Intramuscular Benzathine Penicillin G and Other Penicillin Preparations To Prevent Rheumatic Fever. (Q38755675) (← links)
• Naphthoquine: An Emerging Candidate for Artemisinin Combination Therapy. (Q38807529) (← links)
• Treatment regimens for pregnant women with falciparum malaria (Q38870452) (← links)
• Pharmacokinetics and analgesic effectiveness of intravenous parecoxib for tonsillectomy ± adenoidectomy. (Q39251488) (← links)
• Bradycardia and Hypothermia Complicating Azithromycin Treatment (Q40097878) (← links)
• Modeling C-reactive protein kinetic profiles for use as a clinical prediction tool in patients with Staphylococcus aureus bacteremia (Q40965048) (← links)
• A trial of combination antimalarial therapies in children from Papua New Guinea. (Q41939607) (← links)
• Pharmacokinetic considerations for use of artemisinin-based combination therapies against falciparum malaria in different ethnic populations. (Q46405195) (← links)
• Regarding "Lactation Status and Studies of Pyrimethamine Pharmacokinetics in Pregnancy". (Q47148174) (← links)
• Taste evaluation of a novel midazolam tablet for pediatric patients: In vitro drug dissolution, in vivo animal taste aversion and clinical taste perception profiles. (Q47234952) (← links)
• Simultaneous determination of pentoxifylline, metabolites M1 (lisofylline), M4 and M5, and caffeine in plasma and dried blood spots for pharmacokinetic studies in preterm infants and neonates. (Q47888160) (← links)
• Generation bias in meta-analysis of duration of dual antiplatelet therapy following drug-eluting stent. (Q53153108) (← links)
• Artemether-lumefantrine dosing for malaria treatment in young children and pregnant women: A pharmacokinetic-pharmacodynamic meta-analysis. (Q55449589) (← links)
• Effects of maturation and size on population pharmacokinetics of pentoxifylline and its metabolites in very preterm infants with suspected late-onset sepsis or necrotizing enterocolitis: a pilot study incorporating clinical outcomes (Q59573977) (← links)
• Validation of a Dried Blood Spot Ceftriaxone Assay in Papua New Guinean Children with Severe Bacterial Infections (Q59573978) (← links)
• A novel, palatable paediatric oral formulation of midazolam: pharmacokinetics, tolerability, efficacy and safety (Q59573980) (← links)
• Primary lateral sclerosis-like picture in a patient with a remote history of anti-N-methyl-D- aspartate receptor (anti-NMDAR) antibody encephalitis (Q59573982) (← links)